Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK1059615 in Patients with Solid Tumors or Lymphoma
GSK1059615
PIK111051
NCT00695448
Solid Tumours
Phase 1
 
August 2015

Powered by ideaPoint, Inc.